Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
CME Group Inc banner

CME Group Inc
NASDAQ:CME

Watchlist Manager
CME Group Inc Logo
CME Group Inc
NASDAQ:CME
Watchlist
Price: 231 USD 4.61% Market Closed
Market Cap: $83.7B
Write Note Create Alert Ask AI

Wall St Price Targets

CME Price Targets Summary
CME Group Inc

Wall Street analysts forecast CME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CME is 309.21 USD with a low forecast of 232.3 USD and a high forecast of 370.65 USD.

CME Lowest Forecast
232.3 USD
1% Upside
CME Average Forecast
309.21 USD
34% Upside
CME Highest Forecast
370.65 USD
60% Upside
Lowest Forecast
Price Target
232.3 USD
1% Upside
Average Forecast
Price Target
309.21 USD
34% Upside
Highest Forecast
Price Target
370.65 USD
60% Upside
CME Group Inc Competitors:
Price Targets
QLINEA
Q linea AB
199% Upside
KMI
Kinder Morgan Inc
14% Upside
QLINEA
Q linea AB
199% Upside
KMI
Kinder Morgan Inc
14% Upside

Revenue
Forecast

11% / Year
Past Growth
-13% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
11% / Year
Past Growth
-13% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -13%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

14% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
14% / Year
Past Growth
-17% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is -17%.

What are analyst estimates?

Pre-Tax Income
Forecast

9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
9% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.

What are analyst estimates?

Net Income
Forecast

12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
12% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 7%.

What are analyst estimates?

Continue CME Research

Summary
CME intrinsic value, competitors valuation, and company profile.
DCF Valuation
CME stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CME stock valuation using valuation multiples.
Wall St Estimates
CME price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CME stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other CME Group Inc listings:
LSE • USD
0HR2
 F • EUR
MX4A
 XBER • EUR
MX4A
 XMUN • EUR
MX4A
 SWB • EUR
MX4A
 DUS • EUR
MX4A
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CME's stock price target?
Price Target
309.21 USD

According to Wall Street analysts, the average 1-year price target for CME is 309.21 USD with a low forecast of 232.3 USD and a high forecast of 370.65 USD.

What is the Revenue forecast for CME Group Inc?
Projected CAGR
-13%

Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 3 years is -13%.

What is the Operating Income forecast for CME Group Inc?
Projected CAGR
-17%

Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 3 years is -17%.

What is the Pre-Tax Income forecast for CME Group Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.

What is the Net Income forecast for CME Group Inc?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 3 years is 7%.

Back to Top
ALPHA SPREAD
Follow us
Join 345,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett